Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
HighRes Biosolutions
What AI says about HighRes Biosolutions
HighRes Biosolutions specializes in lab automation solutions that enhance the efficiency and precision of scientific workflows. Their offerings empower life science organizations to implement intelligent data and automation systems, facilitating faster and more reliable scientific discoveries.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
CellarioOS
An orchestration platform that integrates devices, data, and decision logic for automated laboratory workflows.
Nucleus Automation Infrastructure
Next-generation modular automated solutions designed to optimize laboratory hardware and software.
Modular Automated Work Cells
Pre-configured work cells optimized for various applications like NGS prep and high-throughput screening.
Common Questions
What types of laboratories can benefit from HighRes automation solutions?
HighRes automation solutions are designed for a wide range of laboratories, from startups to large pharmaceutical companies, enhancing workflows in drug discovery, genomics, and synthetic biology.
How does CellarioOS improve laboratory workflows?
CellarioOS centralizes control over laboratory devices and data, enabling precise, traceable, and flexible management of complex workflows.
What is the significance of modular automation in labs?
Modular automation allows laboratories to quickly adapt their configurations to meet evolving scientific needs, enhancing efficiency and collaboration.
Where is HighRes Biosolutions headquartered?
HighRes Biosolutions is headquartered in Beverly, Massachusetts, approximately 25 miles north of downtown Boston.
When was HighRes Biosolutions founded?
HighRes Biosolutions was founded in 2004.